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Sonic Hedgehog (Shh) is expressed in the thymus, where it regulates T cell development. Here we
investigated the inﬂuence of Shh on thymic epithelial cell (TEC) development. Components of the
Hedgehog (Hh) signalling pathway were expressed by TEC, and use of a Gli Binding Site-green ﬂuo-
rescence protein (GFP) transgenic reporter mouse demonstrated active Hh-dependent transcription in
TEC in the foetal and adult thymus. Analysis of Shh-deﬁcient foetal thymus organ cultures (FTOC)
showed that Shh is required for normal TEC differentiation. Shh-deﬁcient foetal thymus contained fewer
TEC than wild type (WT), the proportion of medullary TEC was reduced relative to cortical TEC, and cell
surface expression of MHC Class II molecules was increased on both cortical and medullary TEC pop-
ulations. In contrast, the Gli3-deﬁcient thymus, which shows increased Hh-dependent transcription in
thymic stroma, had increased numbers of TEC, but decreased cell surface expression of MHC Class II
molecules on both cortical and medullary TEC. Neutralisation of endogenous Hh proteins in WT FTOC led
to a reduction in TEC numbers, and in the proportion of mature Aire-expressing medullary TEC, but an
increase in cell surface expression of MHC Class II molecules on medullary TEC. Likewise, conditional
deletion of Shh from TEC in the adult thymus resulted in alterations in TEC differentiation and conse-
quent changes in T cell development. TEC numbers, and the proportion of mature Aire-expressing
medullary TEC were reduced, and cell surface expression of MHC Class II molecules on medullary TEC
was increased. Differentiation of mature CD4 and CD8 single positive thymocytes was increased,
demonstrating the regulatory role of Shh production by TEC on T cell development. Treatment of human
thymus explants with recombinant Shh or neutralising anti-Shh antibody indicated that the Hedgehog
pathway is also involved in regulation of differentiation from DP to mature SP T cells in the human
thymus.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The thymus provides a specialised environment for the pro-
duction of T cells. Thymic epithelial cells (TECs) are an essential
component of the thymic stroma, and are required to support T cell
development. Two broad categories of TEC, which are believed to
arise from a common progenitor, have been deﬁned by their
localisation, function and cell surface markers [1,2]. Cortical(c)TEC
provide Dl4 for T cell fate speciﬁcation, and present MHC þ peptide
ligands for positive selection. They are deﬁned as EpCam1þ, CD40þ,
CD205þ, Ly51þ and MHCIIþ, and express genes for antigen pre-
sentation, including Cathepsin-L, Prss16 and b5t. Medullary (m)TEC
are specialised for negative selection, and are deﬁned as surface
EpCamþ, CD40þ, CD205, Ly51 and MHCIIþ cells that react withn).
r Ltd. This is an open access articlethe lectin UEA-1. SomemTEC express the Aire gene and Cathepsin-S,
facilitating expression and presentation of Tissue Restricted Anti-
gens for induction of tolerance. While TEC provide multiple
essential signals for T cell development, they also require signals
from thymocytes for their maturation.
Aire function in mTEC is essential for the induction of tolerance
to self in both humans and mice, and Aire mutation leads to pro-
found multi-organ autoimmunity [3,4]. Other factors which regu-
late mTEC differentiation and function are also likely to inﬂuence
self-tolerance, but currently TEC differentiation is not well under-
stood. To date, only a few factors have been identiﬁed that are
required for TEC differentiation, such as the transcription factor
FoxN1, which when expressed ectopically can programme other
lineages to a TEC fate [5].
During foetal thymus ontogeny, TEC differentiation has been
deﬁned in terms of cell surface expression of CD40 and CD205. The
TEC progenitor population, which is bipotential for cTEC and mTECunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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gradual acquisition of CD40 and increase in CD205 expression gives
rise to a transitional progenitor, able to differentiate into either
functional cTEC, or into mature mTEC that lose CD205 expression
and acquire the expression of mTEC characteristic markers, such as
Aire [8,9]. These observations are consistent with another study
which showed that Aire-expressing mTEC originate from b5tþ
precursors, a molecule expressed in mature cTECs and not in other
cell types [10]. Although these markers have proved useful for
investigating TEC development, the lineage relationship between
mTEC and cTEC populations and the factors that drive the pro-
gression from bipotent progenitors, through transitional in-
termediates, to mature TEC are not well understood in foetal or
post-natal thymus [1].
Interactions between TEC and thymocytes have been shown to
promote the terminal differentiation of TEC lineages, particularly
mTEC, but fate speciﬁcation to either lineage is believed to occur
independently of signals from thymocytes [11]. Relatively few
secreted factors or cellecell interactions have been identiﬁed that
regulate TEC differentiation, although members of the tumour
necrosis factor receptors super family (TNFRSF), including RANK
(TNFRST11a), and CD40 and TGF-b are required for normal thymus
medulla development, growth and function [12e14].
Here, we investigate the role of Sonic Hedgehog (Shh) in the
regulation of TEC development. Shh is one of three mammalian
Hedgehog proteins (Shh, Indian hedgehog (Ihh) and DesertFig. 1. Hedgehog signalling is active in thymic epithelial cells from adult mice. (AeC) G
sorted cTEC and mTEC extracted from 4 week-old mice. (D) Hh signalling in TEC measured
GFP expression in mature MHCIIhigh and immature MHCIIlow mTEC. Numbers within plots i
Data representative of three independent experiments.Hedgehog (Dhh)) which share a common signalling pathway.
Hedgehog proteins signal by binding to their cell surface receptor
Patched1 (Ptch1), and this binding releases Ptch1's repression of
Smoothened (Smo), allowing Smo to transduce the Hh signal. At the
end of the signalling pathway are the Hh-responsive transcription
factors, Gli1, Gli2 and Gli3. Gli1 is itself an Hh-target gene, and
encodes an activator of transcription, whereas Gli2 and Gli3 can be
processed to function as transcriptional activators (in the presence
of Hh pathway activation) or transcriptional repressors (in the
absence of Hh pathway activation). Gli2 is required to intiate the Hh
signal, and functions largely as a transcriptional activator in vivo,
whereas Gli3 functions predominantly as a transcriptional
repressor in vivo, and can act to repress Shh transcription (by
repression of an intermediate transcriptional activator) [15]. In fact,
in many tissues, Shh and Gli3 have opposing functions, with Shh-
deﬁciency and Gli3-deﬁciency giving opposing phenotypes [15].
Hedgehog proteins are expressed in the thymus [16e18], and
signal to developing T cells to promote differentiation and prolif-
eration of early thymocyte progenitors [19,20]. In both mouse and
human studies, Hh signalling has been shown to negatively regu-
late pre-TCR induced differentiation from CD4CD8 double
negative (DN) to CD4þCD8þ (DP) cell [17,21e23]. In addition, in
mouse studies, Shh has been shown to inhibit TCR-induced differ-
entiation from DP to mature CD4 and CD8 single positive (SP)
thymocytes [24e27]. Sonic hedgehog (Shh) is expressed by thymic
stromal cells, and immunoﬂuorescence has located these cellsene expression by microarray [41] of components of the Hh signalling pathway from
by Gli-mediated GFP expression using a reporter transgenic (GBS-GFP-transgenic). (E)
ndicate percentage of GFP positive cells and mean ﬂuorescence intensity (MFI). (D-E).
Fig. 2. Hedgehog signalling during foetal TEC ontogeny. Gli-mediated GFP expression was measured by ﬂow cytometry on the indicated days of embryonic (E) development in
GBS-GFP-transgenic thymi. Developing TEC were identiﬁed as CD45EpCAMþ, and stained with anti-CD40 and anti-CD205 to identify three immature TEC populations on E14.5,
E16.5 E18.5, and cTEC and mTEC on E21.5 (neonate) (AeD): CD40lowCD205low (containing TEC progenitors), CD40intCD205high (immature cTEC) and CD40high CD205low (mTEC
lineage); and in neonatal thymus, showing GFP in mTEC and cTEC populations. Open histograms show GFP-ﬂuorescence in a GBS-GFP transgenic thymus and ﬁlled histograms WT
(background ﬂuorescence). Data representative of three independent experiments.
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[17,18,20]. Dhh has also been shown to be expressed primarily by
stromal cells [18], whereas Ihh is expressed by both stromal cells
and thymocytes, with highest expression detected in the DP thy-
mocytes [22].
Given the pivotol role of the thymus in preventing autoimmu-
nity, it is of interest that Hedgehog pathway genes and Hedgehog-
pathway targets have been identiﬁed in genome wide association
studies (GWAS) for the human autoimmune disorder primary
biliary cirrhosis, and in primary open-angle glaucoma (POAG),
which may be associated with autoimmunity [28,29]. In addition,
components of the Hedgehog-pathway have been detected in sera
from patients with Rheumatoid arthritis, Lupus and ankylosing
spondylitis [50]. In the human thymus, Hedgehog proteins are
expressed by TEC and have been shown to signal to developing
thymocyte progenitors, and aberrant Hedgehog pathway activation
has been observed in both T acute lymphoblastic leukaemia (T-ALL)
and thymoma, which is associated with the neuromuscular auto-
immune disorder Myasthenia gravis [18,23,30e34].
Here we analyse the function of Hedgehog signalling in TEC. We
show that developing TEC also express components of the Hh
signalling pathway and transduce Hh signals in the foetal and adult
thymus. We show that Shh is required for normal TEC develop-
ment, and that it particularly inﬂuences the mTEC lineage.
2. Materials and methods
2.1. Mice
C57BL/6 mice were purchased from Harlan. Gli Binding Site
(GBS)-GFP transgenic mice were provided by James Briscoe [35],
and Shhþ/ mice by Phillip Beachy [36], ShhF/F and Gli3þ/ mice
were purchased from The Jackson Laboratories.
ShhF/F were crossed with FoxN1-Cre transgenic mice [37]. Mice
were bred and maintained at UCL. All mice studies were reviewed
and approved by the British Home Ofﬁce.
2.2. FTOC and culture of human thymus explants
E14.5 Foetal thymi were cultured as described [38] for seven
days before analysis. In some experiments, recombinant rHhip
(SigmaeAldrich) was used at 1 mg/ml.
For culture of human thymus explants, human thymus tissue
was obtained after surgical removal in children undergoing
corrective cardiac surgery. The study had full ethical approval from
the Local Research Ethics Committee; in accordance with the
Declaration of Helsinki, fully informed consent was obtained from
parents of all child donors. The human thymus tissue was cut into
~1 mm cubed fragments using a scalpel, and cultured on 0.8 mm
Millipore ﬁlters (Millipore, Massachusetts, US) on 1 ml AIM-V
serum free medium (Invitrogen, US) in 24-well plates for ﬁve
days before analysis. Recombinant Shh protein (at 0.5, 0.25 or
0.125 mg/ml) (R&D Systems) or the anti-Shh neutralising antibody
5E1 (5 mg/ml), as described previously [17], were added where
stated.Fig. 3. Reduced TEC differentiation in the E15.5 Shh¡/¡ thymus and Shh¡/¡ FTOC compa
staining on CD45-cells in Shhþ/þ and Shh/ thymus, giving the percentage of cells that stain
positive with anti-EpCam1 (upper chart), and number of CD45EpCam1þ cells (lower cha
tograms correspond to isotype controls. Bar charts show the mean percentage of EpCa
CD45EpCam1þCD205þ cells (lower chart). N ¼ 4 for both genotypes. Data represent mean
and WT litter mate FTOC were cultured for 7 days and TEC populations were analysed by ﬂo
epithelial cells (CD45EpCam1þ) isolated from Shh/, and WT FTOC. (E) Anti-Ly51 (cTEC) a
showing the percentage of cells within the region. (F) Bar charts show mean percentage of e
of cTEC and of mTEC isolated from Shh/ and WT FTOC. (G) Histograms show cell surface MH
histogram) FTOC. Bar charts show mean of MFI for cell surface MHCII staining on cTEC and2.3. Isolation of epithelial cells from embryonic and adult thymus
For isolation of adult TEC, thymic lobes were dissected and cut
into small pieces (~10 mm  10 mm), excess thymocytes removed
by sequential washes in HBSS containing FCS 10% (v/v) and incu-
bated for 30 min at 37 C in HBSS containing FCS, 3.3 mg/ml Lib-
erase and 0.5 mg/ml DNaseI (Roche Diagnostics UK). After
incubation, cells suspensions were prepared by gentle mechanical
dissociation.
For isolation of embryonic TEC, thymic lobes were dissected and
washed once in PBS followed by an incubation of 15 min in PBS
containing 0.25% trypsin and 0.02% EDTA and gentle mechanical
dissociation to obtain cell suspensions.
2.4. PCR analysis for genotyping
DNA for PCR analysis was extracted from tissue as described
[39]. Approximately 1 mg of DNAwas used as a template in each PCR
reaction, using primers as described in Refs. [37] and [19].
2.5. Antibodies and Flow cytometry
Cells were stained as described [40,41,9] using directly conju-
gated antibodies against the markers stated (eBioscience; BD
PharMingen; and Biolegend, US). Identiﬁcation of mTEC pop-
ulations was done using the lectin UEA-1 (Vector Labs, UK). For
intracellular Aire staining cells were ﬁxed and permeabilised using
the IC ﬁxation/permeabilisation kit (eBioscience).
Experiments were acquired on a Becton Dickinson LSR-II and
data representative of >3 experiments analysed using Flowjo 10.6
(Tree Star, US).
2.6. Microarray data normalisation
Publicly available gene-expression microarray datasets per-
formed on RNA from wild type highly puriﬁed TEC [41] were ana-
lysed for the expression of several components of the Hh signalling
pathway. Packages “affy” and R were used for quality control and
normalisation of the datasets by log-scale Robust Multi-Array
analysis (RMA).
2.7. Statistical analysis
Statistical analysis was performed using unpaired two-tailed t-
tests and probabilities considered signiﬁcant if P  0.05 (*),
P  0.001 (**) and P  0.0001 (***). Data were analysed using Prism
5.0 (GraphPad INC US).
3. Results
3.1. Hedgehog signalling is active in thymic epithelial cells (TEC) of
adult mice
We have previously shown that the components of the Hedge-
hog signalling pathway are expressed by foetal thymic stroma, [42].red to WT. (AeB) TEC populations in E15.5 thymus. (A) Histograms show anti-EpCam1
positive with anti-EpCam1. Bar charts show mean percentage of CD45-cells that stain
rt). (B) Histograms show CD205 expression on CD45EpCam1þ cells, and shaded his-
m1þCD45 cells that stain positive with CD205 (upper chart) and the number of
± SD **p < 0.001 ***p < 0.0001. (CeG) TEC populations in Shh/ and WT FTOC. Shh/
w cytometry. (C) Number of cells recovered from Shh/ and WT FTOC. (D) Number of
nd UEA-1 (mTEC) staining on CD45EpCam1þ cells isolated from Shh/ and WT FTOC,
pithelial cells that are cTEC (Ly51þ) and mTEC (UEA-1 staining), and the mean number
CII staining on cTEC and mTEC isolated from Shh/ (shaded histogram) andWT (open
mTEC isolated from Shh/ and WT FTOC.
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speciﬁcally by TEC, we analysed microarray datasets performed on
highly pure sorted TEC populations [41] to assess the expression of
Shh, the Shh-receptor Ptch1, the signal transducer Smo and the
three Hh-responsive transcription factors (Gli1, Gli2 and Gli3).
Transcripts for Shh and the signal transducers Gli1-3were detected
both in cortical and medullary TEC (Fig. 1A and B). Transcripts for
the transcriptional activator Gli1 were low in both TEC sub-
populations whereas transcripts for Gli2 and Gli3, whose products
can act either as transcriptional activators or repressors, were
detected at signiﬁcantly higher concentrations in cTEC when
compared to mTEC (Fig. 1B). In addition, Smo and Ptch1were highly
expressed in both TEC subpopulations (Fig. 1C). Taken together, this
transcriptional analysis suggested that (autocrine) Shh signalling is
likely to occur in TEC.
We next wished to demonstrate active Hedgehog signalling in
TEC using a Gli binding site (GBS)-GFP reporter transgenic [35] and
determine the proportion of epithelia that display Gli-mediated
transcription. Using this transgenic system to measure Hh
signaling activity in the adult thymus, we observed that a higher
frequency of mTEC showed active signalling (11.3%) when
compared to cTEC (3.9%; Fig 1D). This difference is consistent with
the higher expression of the transcriptional repressor Gli3 in cTEC
(Fig 1B). Most of the mTEC undergoing Hedgehog signalling (GFPþ)
displayed a mature phenotype, as measured by the expression of
high levels of cell surface MHCII, and approximately half of
MHCIIhigh mTEC were GFPþ (Fig. 1E). These data thus indicate that
adult TEC are undergoing active Hh-signalling, particularly in the
mature MHCIIhigh mTEC subset.3.2. Hedgehog signalling is active in developing TEC
To assess whether Hh signalling is active in TEC during foetal
thymus development, we used the Gli Binding Site (GBS)-GFP
reporter transgenic to analyse GFP expression in populations of
developing TEC, deﬁned by the changing expression of the
developmental markers CD40 and CD205 [8,9]. We analysed TEC
populations on E14.5, E16.5, E18.5 and E21.5 (neonate). We
detected GFP expression in all TEC populations, deﬁned by CD40
and CD205 expression (Fig. 2). GFP expression was overall highest
in terms of mean ﬂuorescence intensity (MFI) and percentage of
positive cells early during development (on E14.5 and E16.5,
Fig. 2A and B) with intensity declining through out ontogeny. On
E16.5 (Fig. 2B) we found that both CD40intCD205high and CD40high
CD205low TEC populations expressed similar GFP levels but at the
later E18.5 stage, CD40high CD205low TEC expressed higher GFP
levels, indicating greater Hh signalling (Fig. 2C). At this time in
development, these are cells that are likely to have downregulated
CD205 and speciﬁed to the mTEC lineage. In the neonatal thymus,
the intensity of GFP expression had declined, but GFP was still
detectable in both cTEC and mTEC lineages (Fig. 2D). Thus,
developing TEC have Gli-mediated transcriptional activity in theFig. 4. TEC differentiation in Gli3¡/¡ FTOC compared to WT, and in rHhip-treated WT FTO
days and TEC populations were analysed by ﬂow cytometry. (A) Bar chart shows mean num
show cell surface MHCII staining on cTEC and mTEC isolated from Gli3/ and WT FTOC. S
surface MHCII staining on cTEC and mTEC isolated from Gli3/ and WT FTOC. Data represen
littermates **p < 0.001 ***p < 0.0001. (CeG) rHhip treatment modulates TEC differentiatio
with rHhip for 7 days, compared to control untreated FTOC. (C) Histograms show anti-EpCam
percentage and number of EpCam1þ cells. (D) Dot plots show anti-Ly51 (cTEC) and UEA-1 (
Bar charts showmean percentage and number of Ly51UEA-1þ (mTEC). (E) Bar charts show
from treated and control FTOC. (F) Contour plots show cell surface anti-MHCII staining and in
rHhip-treated FTOC, showing the percentage of cells that stained positive for both marke
(CD45EpCam1þUEA-1þ) that are positive with intracellular anti-Aire staining and anti MH
from n ¼ 3. Data represent mean ± SD, *p < 0.05.foetal thymus, suggesting a role for the Hh pathway during their
development.3.3. Foetal TEC development requires Shh
To test whether Shh is required for foetal TEC development, we
analysed TEC development in Shh/ embryos. Shh-deﬁciency is
embryonic lethal, and Shh is expressed by TEC in the foetal and
adult thymus (Fig. 1A) [17,18]. Previous studies have shown that the
Shh/ thymus contains fewer thymocytes than wild type (WT),
with inefﬁcient expansion and differentiation of early CD4CD8
(DN) thymocytes [19,22], but accelerated pre-TCR dependent dif-
ferentiation fromDN to CD4þCD8þ double positive (DP) thymocyte,
and increased efﬁciency of differentiation fromDP to single positive
(SP) thymocyte in vitro [21,43]. These defects in thymocyte devel-
opment could be the consequence of loss of direct Shh-signalling
from TEC to thymocytes, or alternatively could result indirectly
due to changes in the thymopoietic capacity of TEC, leading to an
indirect effect on thymocytes.
As Shh deletion is embryonic lethal, and most embryos die
before E16, we ﬁrst examined TEC development in the E15.5 foetal
thymus. As described previously, the E15.5 Shh/ thymus was
smaller than WT [19]. The number of CD45EpCam1þ (epithelial
lineage cells) was reduced (Fig 3A), and cell surface expression of
CD205, and the percentage of CD205þ cells within the EpCam1þ
population were also reduced, relative to WT (Fig. 3B). In order to
analyse TEC development in the absence of Shh at later stages of
their differentiation, we used foetal thymus organ culture (FTOC) to
compare development of Shh/ and WT TEC (Fig. 3CeG). Shh/
and WT littermate thymus lobes were cultured for 7 days
(Fig. 3CeG). The number of cells recovered from Shh/ thymi was
decreased (Fig. 3C) and therewas an overall decrease in the number
of TEC (CD45EpCam1þ cells), relative to WT (Fig. 3D). When we
stained against markers of mature cTEC and mTEC populations,
Ly51 and UEA-1, we found a signiﬁcant change in the frequencies of
cTEC and mTEC in the Shh-deﬁcient thymus, with a marked
reduction in mTEC (Fig. 3EeF). The percentage of mTEC was
reduced from 27.4% in theWT FTOC to 13.2% in Shh/ FTOC, with a
concomitant increase in the proportion of cTEC (Fig. 3E). Overall,
both the number of cTEC and the number of mTEC were signiﬁ-
cantly reduced in Shh/ FTOC compared toWT FTOC, although the
mTEC population was affected more severely than cTEC (Fig. 3F).
Cell-surface expression of MHCII is essential for both the role of
cTEC in positive selection, and the role of mTEC in negative selec-
tion, and high cell surface MHCII expression is a marker of mature
mTEC. Interestingly, cell surface expression of MHCII was higher in
Shh/ FTOC compared to WT, in both cTEC and mTEC populations
(Fig. 3G).
Gli3 acts as a suppressor of Shh mediated signalling [15] and the
Gli3-deﬁcient thymus shows increased Hh-mediated transcription
in the thymic stroma [42]. We therefore tested if constitutive loss of
Gli3 expression caused changes in TEC cellularity, differentiationC compared to untreated. (AeB) Gli3/ and WT litter mate FTOC were cultured for 7
ber of epithelial cells recovered from Gli3/ and WT littermate FTOC. (B) Histograms
haded histograms are Gli3/ and open are WT. Bar charts show mean of MFI for cell
t mean ± SD. N ¼ 5 for Shh/ and their WT littermate and N ¼ 3 for Gli3 and their WT
n in WT FTOC. TEC development was analysed by ﬂow cytometry in WT FTOC treated
1 staining on CD45 cells, giving the percentage of positive cells. Bar charts showmean
mTEC) staining on CD45EpCam1þ cells isolated from control and rHhip-treated FTOC.
mean MFI of cell surface anti-MHCII staining on cTEC (left chart) and mTEC (right chart)
tracellular anti-Aire staining, gated on CD45EpCam1þUEA-1þmTEC, from control and
rs. The MFI of MHCII staining is also given. (G) Bar chart shows percentage of mTEC
CII staining. For (C), (D) and (E) data were obtained from n ¼ 7 FTOC and for (F and G)
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FTOC. We observed an increase in TEC numbers in Gli3/ FTOC
relative to WT littermates (Fig. 4A). In addition, TEC from the Gli3-
deﬁcient thymus had lower cell surface MHCII expression in both
cTEC and mTEC populations (Fig. 4B).
3.4. Neutralisation of Hh signalling inﬂuences TEC differentiation in
WT FTOC
Given that Shh is required for normal TEC development in FTOC,
we tested if we couldmanipulate TEC differentiation inWT FTOC by
neutralisation of Hh proteins by treatment with soluble recombi-
nant (r)Hhip. Hhip binds to and sequesters Hh proteins [44], and
therefore reduces the endogenous Hh signal in FTOC. Treatment of
WT FTOC for 7 days with rHhip reduced the proportion of TEC in
the CD45 population from 78.2 to 62.5% (Fig. 4D). Within the
EpCam1þ population, the mTEC lineage (UEA-1þ) was reduced
from 25.2% in untreated FTOC to 16.9% in rHhip-treated FTOC, with
a corresponding decrease in mTEC cell number (Fig. 4D). We
examined cell surface MHCII expression and found that intensity of
staining was signiﬁcantly increased on the mTEC population
(Fig. 5E and F), consistent with the phenotype of Shh/ FTOC (Fig
3G). The MHCIIhigh mTEC population are mature and this popula-
tion contains Aire-expressing mTEC. Interestingly, although MHCII
expression was increased in the rHhip treated cultures, the pro-
portion of mTEC that expressed intracellular Aire protein, declined
(Fig. 4F), from 13.6% in control cultures to 7.45% in treated cultures.
Neutralisation of endogenous Hedgehog proteins in FTOC thus
had a similar effect to Shh-deﬁciency, as TEC numbers, and the
proportion of mTEC were decreased, whereas cell surface MHCII
was increased, highlighting the importance of Hh signals for TEC
differentiation.
3.5. TEC differentiation is reduced in the Shh-deﬁcient adult thymus
To extend our analysis of the role of Shh in TEC differentiation
and maintenance, we generated mice with a TEC-speciﬁc loss of
Shh expression. For this purposewe crossedmice transgenic for the
expression of the Cre recombinase under the Foxn1 promoter to
animals with a conditional Shh allele to conditionally delete Shh
from TEC lineage cells (ShhcoKO). The ShhcoKO thymus contained
fewer cells overall (Fig. 5A), with a profound impact on TEC. There
were fewer TEC than WT (Fig. 5A), and numbers of both cTEC and
mTEC lineage cells were signiﬁcantly reduced, although there was
an increase in the proportion of cTEC relative to mTEC in the
ShhcoKO (Fig. 5BeC). Comparable to the ﬁndings with foetal Shh/
FTOC, cell surface expression of MHCII was increased on mTEC, but
the proportion of mTEC expressing Aire protein was reduced
(Fig. 5DeE).
3.6. Inﬂuence of conditional Shh-deﬁciency on thymocyte
populations
Constitutive Shh-deﬁciency has previously been shown toFig. 5. Conditional deletion of Shh from TEC reduces TEC differentiation in the adult th
Shhﬂoxed mice with FoxN1-Cre transgenics to conditionally delete Shh from TEC. Thymus fr
show overall number of cells (left) and number of TEC (CD45EpCam1þ cells) (right) in the C
staining against Ly51 (cTEC), gated on CD45EpCam1þ cells, from Creþ and Cre-littermate
number of cTEC and mTEC. (D) Contour plots show cell surface anti-MHCII staining and intr
cells in each quadrant and the MFI for anti-MHCII staining are given. (E) The bar chart (left
mean number of mTEC (CD45EpCam1þLy51-UEA-1þ) that are positive with intracellular a
staining on thymus from ShhcoKO and WT mice. Representative percentages of thym
WT ¼ 12.73 ± 1.255, ShhcoKO ¼ 7.833 ± 1.167 (p ¼ 0.0459) and mean DP:CD8 SP ratio WT ¼ 42
(top left), CD5 (top centre), MFI of CD5high SP cells are indicated, and CD24high (top right) exp
cells that stain positive with anti-CD3, anti-CD5 and anti-CD24 in the thymocyte subsets. Dinﬂuence T-cell development at the transition from DP to SP in
FTOC, increasing the proportion of mature SP thymocytes [24].
However, it has not been possible to use the constitutive Shh/
mutants to investigate postnatal T cell development given that a
constitutive loss of Shh expression results in embryonic lethality,
and the inﬂuence of conditional deletion of Shh from TEC on
thymocyte development is not known. We therefore examined the
inﬂuence of conditional deletion of Shh from TEC in the adult
ShhcoKO thymus on SP thymocyte differentiation. The proportions
of CD4SP and CD8SP cells were signiﬁcantly increased in the
ShhcoKO thymus, compared to WT (Cre-) littermates, with con-
commitant signiﬁcant decrease in the DP population (Fig 5F). The
percentage of CD3high cells in the DP, CD4SP and CD8SP pop-
ulations were higher in the ShhcoKO compared to WT thymus (Fig
5G). CD3 is upregulated on DP cells undergoing positive selection,
and its high expression in SP populations indicates maturity of the
cells, so the higher proportion or CD3high cells suggests that dif-
ferentiation from DP to mature SP is heightened in the ShhcoKO.
Consistent with this, expression of the maturation marker CD24
(HSA), which is downregulated in more mature SP cells, was lower
in the ShhcoKO populations, with fewer cells falling in the CD24high
marker (Fig. 5G). In addition, we measured cell surface CD5
expression. Levels of cell surface CD5 expression on thymocytes are
believed to correspond toTCR signal strength [45], and treatment of
WT FTOCwith rShh has been shown to decrease cell surface CD5 on
thymocytes in FTOC [24]. Interestingly, a greater proportion of both
CD4SP and CD8SP cells had high levels of cell surface CD5 in the
ShhcoKO thymus than in WT (Fig. 5G). Overall, the ShhcoKO thymus
showed an increase in both mature SP populations. Thus, secretion
of Shh by TEC is important both for TEC maturation and T-cell
development.
3.7. Shh regulates differentiation from DP to SP in the human
thymus
Shh is expressed by human TEC [18]. Therefore, in order to test
the effect of Shh signalling in human thymocyte differentiation we
treated human thymus explants with rShh or neutralising anti-Shh
antibody for 5 days, and assessed the SP and DP populations by ﬂow
cytometry. Single positive thymocytes accumulated in the thymus
explants, and to analyse the mature SP populations, and exclude
TCR-negative SP cells that occur before the DP population, we gated
on CD3high cells (Fig. 6A) and analysed the percentage of CD4SP,
CD8SP and DP within the CD3high gate (Fig. 6B). Treatment with
rShh decreased the proportion of CD3highCD4SP and CD3highCD8SP
and increased the proportion of CD3highDP cells, with 68.7% of the
CD3high gate being CD4SP cells in control-untreated cultures,
compared to 49.3% in cultures treated with 0.25 mg/ml rShh. There
was a concomitant rise in the DP population, from 13.2% in the
control to 29.1% in the rShh-treated cultures (Fig. 6BeC). The pro-
portion of CD4SP cells was more affected by rShh-treatment than
proportion of CD8SP cells, so that overall the ratio of CD4:CD8 SP
was decreased on rShh treatment, in a dose-dependant manner, as
were the ratios of CD4:DP and SP:DP (Fig. 6D). In contrast, whenweymus. Conditional knockout mice of Shh in TEC (ShhcoKO) were generated by crossing
om Creþ (ShhcoKO) was compared to thymus from Cre- (WT) littermates. (A) Bar charts
re- (control) and Creþ (ShhcoKO) thymus. (B) Dot plots show UEA-1 staining (mTEC) and
s. The percentage of cells within each region is given. (C) Bar charts show the mean
acellular anti-Aire staining, gated on CD45EpCam1þUEA-1þ mTEC. The percentage of
) shows the mean MFI of MHCII staining on mTEC and the bar chart (right) shows the
nti-Aire staining. N ¼ 4 mice per genotype. (F) Dot plots show anti-CD4 and anti-CD8
ocytes from three independent experiments are given. Mean DP:CD4 SP ratio
.30 ± 4.723, ShhcoKO ¼ 25.77 ± 3.453 (p ¼ 0.0475). (G). Offset histograms represent CD3
ression on thymocytes from ShhcoKO and WT mice. Bar charts show mean percentage of
ata represent mean ± SD, *p < 0.05 **p < 0.001 ***p < 0.0001.
Fig. 6. Shh modulates differentiation from DP to SP thymocyte in the human thymus. T cell development was analysed by ﬂow cytometry in human thymus explants treated
with rShh or neutralizing anti-Shh mab (5E1) for 5 days, compared to control untreated explants. (A) Density plot show Forward side scatter (FSC) against anti-CD3 staining,
showing the gate on CD3high thymocytes. (B) Contour plot shows anti-CD4 and anti-CD8 staining on the CD3high gated population in control untreated thymus explants cultured for
5 days. (C) Contour plots show CD4 and CD8 expression in the CD3high gate in thymus explants treated for 5 days with 0.5, 0.25 and 0.125 mg/ml rShh, and 5 mg/ml 5E1 (anti-Shh
neutralizing antibody). (D) The bar-chart shows the ratios of CD4:DP (open bar), CD4SP:CD8SP (grey bar), and SP:DP (black bar) within the CD3high population, under the different
culture conditions. Data are representative of three independent experiments.
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body against Shh, to neutralise the endogenous Hh proteins in the
culture, we found the opposing effect. The accumulation of
CD3highCD4SP cells was increased compared to untreated cultures,
and the ratios of CD4SP:DP, CD4SP:CD8SP and SP:DP were all
increased (Fig. 6BeD). Thus, the action of rShh-treatment or neu-
tralisation of endogenous Hh proteins in human thymus explants,
mirror the inﬂuence of the Hedgehog pathway in the mouse
thymus, where increased Hh signalling reduces differentiation
from DP to SP cell, and reduction in Hh signalling increases differ-
entiation from DP to SP cell [24e27,42].
4. Discussion
Here we show that Hedgehog signalling regulates thedevelopment of TEC during foetal thymus ontogeny, and also in-
ﬂuences TEC production and differentiation in the adult steady-
state thymus. The use of GBS-GFP reporter mice, and Shh/,
ShhcoKO and Gli3/mouse mutants conﬁrmed that Shh is required
for normal TEC differentiation, that it is produced by TEC and that
developing TEC transduce Hh signals.
Interestingly, reduction in Hh signalling to TEC, by Shh-deﬁ-
ciency, conditional deletion of Shh from TEC, or neutralisation of
endogenous Hh proteins in WT FTOC all led to an increase in cell
surface MHCII expression on TEC. Thus, although there are overall
fewer TEC in the Shh-deﬁcient thymus, on each individual TEC
more selecting MHCII plus peptide complexes for positive and
negative selection will be available to developing thymocytes,
potentially inﬂuencing the outcome of TCR repertoire selection by
altering MCHII-restricted TCR antigen dwell time or avidity [46].
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showed increased differentiation from DP to SP cell, whereas
treatment of WT FTOC with rShh decreased differentiation from DP
to SP, and the CD4:CD8 ratio [24]. In addition, inhibition of Gli2-
mediated transcription by transgenic expression of a repressor
form of Gli2 in T-lineage cells increased differentiation from DP to
SP thymocyte [25,26], whereas increased Hh-mediated transcrip-
tion by transgenic expression of an activator form of Gli2 in T-
lineage cells, or by conditional deletion of Ptch1 from T cells
reduced differentiation from DP to SP thymocyte [24,25,47]. Acti-
vation of Hh-mediated transcription in T lineage cells has been
shown to decrease TCR signal strength [24,48], providing an
explanation for the decrease in differentiation from DP to SP on Hh
pathway activation and relatively greater impact on the CD4SP
lineage on treatment of WT FTOC with rShh. However, our data
here suggest that another way in which Shh might impact on dif-
ferentiation fromDP to SP cell is tomodulate cell surface expression
of MHCII on TEC, inﬂuencing signals for positive selection to the
CD4 lineage.
Treatment of human thymus explants with rShh or neutralising
anti-Shh antibody indicated that Shh also inﬂuences differentiation
from DP to SP cell, thus underscoring the relevance of these mouse
models to human immunity and disease. In both human GWAS
studies, patients and experimental animal models, the Hedgehog
signalling pathway and its gene targets have been implicated in
autoimmunity and allergy [28,49e53], but genetic susceptibilities
to different autoimmune diseases are complex [54e57], so in the
future it will be interesting to assess the speciﬁc contribution of
Hedgehog signalling in TEC differentiation and function to the in-
duction and severity of human autoimmune diseases. Interestingly,
in primary biliary cirrhosis patients, GWAS have identiﬁed both the
Hedgehog pathway genes and MHCII genes [54], supporting the
idea that the inﬂuence of Shh on MHCII expression in the thymus
might be important for central tolerance of the CD4 population.
It is important to highlight the inﬂuence of Shh on TEC devel-
opment. Normal differentiation and cellularity of medullary TEC,
including the mature MHCIIhigh Aireþ mTEC population, is altered
in the absence of Shh production by TEC or by neutralization of
endogenous Hh signals. These observations are consistent with the
role of other morphogens such as TGF-b, which also negatively
regulates mTEC maturation and growth, with the adult TGF-b
conditional knockout showing a similar proportional change in the
mTEC population as we observed in the adult ShhcoKO thymus [14].
Gradient signalling by morphogens such as Shh could ﬁne-tune the
correct induction of central T-cell tolerance.
5. Conclusions
 Few factors that inﬂuence TEC differentiation have been iden-
tiﬁed, and here we show that morphogens, such as Sonic
Hedgehog, play an important role in this process.
 Alterations in the Shh signalling pathway have an impact on
mTEC development and MHCII surface expression with poten-
tial to alter T cell central tolerance.
 It will in the future be important to investigate the impact of Shh
signalling to TEC on other known signals required for mTEC
development and function such as TNFRST11a and TGF-b, and
the way in which Hh pathway activation integrates with RANK
or TGF-b signalling.
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